Jiangsu Hanbon Science and Technology Co., Ltd. (SHA:688755)
China · Delayed Price · Currency is CNY 40.92
-0.07 (-0.17%)
At close: Feb 27, 2026
SHA:688755 Revenue
Jiangsu Hanbon Science and Technology had revenue of 157.01M CNY in the quarter ending September 30, 2025, with 1.67% growth. This brings the company's revenue in the last twelve months to 713.17M, up 11.11% year-over-year. In the year 2024, Jiangsu Hanbon Science and Technology had annual revenue of 690.88M with 11.61% growth.
Revenue (ttm)
713.17M
Revenue Growth
+11.11%
P/S Ratio
5.05
Revenue / Employee
1.09M
Employees
689
Market Cap
3.60B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 690.88M | 71.87M | 11.61% |
| Dec 31, 2023 | 619.01M | 137.22M | 28.48% |
| Dec 31, 2022 | 481.79M | 161.28M | 50.32% |
| Dec 31, 2021 | 320.51M | 18.23M | 6.03% |
| Dec 31, 2020 | 302.28M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Beijing Bashi Media | 4.30B |
| Zhejiang Red Dragonfly Footwear | 1.98B |
| Jiangsu Liba Enterprise Joint-Stock | 1.71B |
| China Railway High-speed Electrification Equipment Corporation | 1.18B |
| Shaanxi Meibang Pharmaceutical Group | 871.63M |
| Shanghai Lianming Machinery | 850.23M |
| Zhejiang Shengda Bio-Pharm | 839.82M |
| Hangzhou Kaierda Welding Robot | 610.04M |